These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21094232)

  • 1. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting.
    Lai LF; Guo HX
    Int J Pharm; 2011 Feb; 404(1-2):317-23. PubMed ID: 21094232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C; Chen D; Gu J; Qin J
    J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and passive target of 5-fluorouracil solid lipid nanoparticles.
    Du B; Yan Y; Li Y; Wang S; Zhang Z
    Pharm Dev Technol; 2010; 15(4):346-53. PubMed ID: 19769532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
    Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
    Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.
    Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE
    Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.
    Luo Y; Zhang B; Whent M; Yu LL; Wang Q
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):145-52. PubMed ID: 21440424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.
    Patel MN; Lakkadwala S; Majrad MS; Injeti ER; Gollmer SM; Shah ZA; Boddu SH; Nesamony J
    AAPS PharmSciTech; 2014 Dec; 15(6):1498-508. PubMed ID: 25035070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles.
    Nanjwade BK; Singh J; Parikh KA; Manvi FV
    Int J Pharm; 2010 Jan; 385(1-2):176-80. PubMed ID: 19854254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
    Wang M; Yuan Y; Gao Y; Ma HM; Xu HT; Zhang XN; Pan WS
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1134-41. PubMed ID: 22182601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles.
    Sairam M; Babu VR; Vijaya B; Naidu K; Aminabhavi TM
    Int J Pharm; 2006 Aug; 320(1-2):131-6. PubMed ID: 16766148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
    Hao X; Cheng G; Zou M; Sun J; Cui F
    Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach.
    Kulthe SS; Bahekar JK; Godhani CC; Choudhari YM; Inamdar NN; Mourya VK
    Drug Dev Ind Pharm; 2013 Jan; 39(1):138-45. PubMed ID: 22369145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
    Pawar AA; Chen DR; Venkataraman C
    Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.